| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $40.17M | $16.83M | $14.26M | $23.38M | $8.29M |
| R&D | $33.38M | $10.64M | $7.88M | $16.09M | $4.63M |
| SG&A | $6.79M | $6.19M | $6.38M | $7.29M | $3.66M |
| Operating Income | -$40.17M | -$16.83M | -$14.26M | -$23.38M | -$8.29M |
| Interest Expense | – | – | – | $282.06K | $416.29K |
| Tax Expense | – | $0.00 | $0.00 | $0.00 | – |
| Net Income | -$39.72M | $2.78M | -$13.21M | -$18.06M | -$9.79M |
| EPS (basic) | -22.6100 | 0.1100 | -1.0700 | -2.4100 | -1.6900 |
| EPS (diluted) | -22.6100 | 0.1100 | -1.0700 | -2.4100 | -1.6900 |
| Shares (diluted) | $1.76M | $26.46M | $12.29M | $7.50M | $5.79M |